Squarepoint’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,500
Closed -$729K 4895
2025
Q3
$729K Sell
6,500
-11,700
-64% -$1.37M ﹤0.01% 2921
2025
Q2
$2.44M Sell
18,200
-6,100
-25% -$670K ﹤0.01% 1950
2025
Q1
$1.63M Buy
+24,300
New +$1.67M ﹤0.01% 2257

Other funds holding TMDX

Squarepoint's TMDX Position: Q1 2026 in Review

Squarepoint reduced its Transmedics (TMDX) stake by 93% in Q1 2026, selling an estimated $13.5M and leaving 7,274 shares worth $723K. The position accounts for ﹤0.01% of the portfolio, ranked #3041.

Squarepoint first reported a position in TMDX in Q2 2019 and has held it in 23 quarters since. The position peaked at $35.6M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Squarepoint held 7,274 shares of Transmedics worth $723K as of Q1 2026.
  • Squarepoint sold 103,222 Transmedics shares in Q1 2026, an estimated $13.5M.
  • Transmedics made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3041 holding.
  • Squarepoint first reported a position in Transmedics in Q2 2019 and has held it in 23 quarters since.
  • Squarepoint's Transmedics position peaked at $35.6M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.